![Erik Emerson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erik Emerson
Algemeen Directeur bij
GLUCOTRACK
Vermogen: 668 429 $ op 31-07-2026
Profiel
Erik Emerson was the founder of Symplmed Pharmaceuticals LLC, founded in 2013, where the title held was President & Chief Executive Officer from 2013 to 2018.
Current jobs include Chief Executive Officer & Director at GlucoTrack, Inc. starting in 2026, and Chief Executive & Director at Lokahi Therapeutics, Inc. starting in 2025.
Former jobs include Director at Adhera Therapeutics, Inc. in 2019; Marketing Director at Gilead Sciences, Inc. from 2007 to 2010; Senior Director-Commercial Development at XOMA Royalty Corp.
from 2010 to 2013; President & Director at Apimeds Pharmaceuticals US, Inc. from 2025 to 2026; Chief Commercial Officer at Mezzion Pharmaceuticals, Inc. from 2017 to 2020; and Chief Commercial Officer at Odyssey Health, Inc. from 2022 to 2023.
Education includes undergraduate studies at the University of Oregon.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
4,97% | 15-10-2025 | 75.000 ( 4,97% ) | 386 250 $ | 31-07-2026 |
GLUCOTRACK INC 7,66% | 10-08-2026 | 591.570 ( 7,66% ) | 282 179 $ | 31-07-2026 |
Actieve functies van Erik Emerson
| Bedrijven | Functie | Begin |
|---|---|---|
| GLUCOTRACK | Algemeen Directeur | 14-07-2026 |
Eerdere bekende functies van Erik Emerson
| Bedrijven | Functie | Einde |
|---|---|---|
| ODYSSEY HEALTH, INC. | Corporate Officer/Principal | 01-10-2023 |
Mezzion Pharmaceuticals, Inc.
 Mezzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug manufacturing company | Corporate Officer/Principal | 01-01-2020 |
| ADHERA THERAPEUTICS, INC. | Directeur/Bestuurslid | 19-12-2019 |
Symplmed Pharmaceuticals LLC
 Symplmed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Algemeen Directeur | 01-05-2018 |
Opleiding van Erik Emerson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
55
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
GlucoTrack, Inc.
 GlucoTrack, Inc. Medical SpecialtiesHealth Technology Develops a non-invasive glucose monitoring device | Health Technology |
Odyssey Health, Inc.
 Odyssey Health, Inc. Medical SpecialtiesHealth Technology Develops heart monitoring and screening devices | Health Technology |
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adhera Therapeutics, Inc.
 Adhera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hypertensive drugs | Health Technology |
Symplmed Pharmaceuticals LLC
Symplmed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Mezzion Pharmaceuticals, Inc.
Mezzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug manufacturing company | Health Technology |
